- Investing Ideas
- /
- Swedish Small Cap High Growth Stocks
Swedish Small Cap High Growth Stocks
Results
167
0 new
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
167 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.51 | 0.4% | 0.3% | SEK 408.4m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
NEWBRY | SEK 3.58 | 5.9% | -12.9% | SEK 86.8m | SEK 8.00 | PS4.7x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
CLBIO | SEK 12.60 | -0.4% | -24.3% | SEK 270.8m | SEK 29.00 | PS8.8x | E114.8% | n/a | Pharmaceuticals & Biotech | ||
ENRAD | SEK 15.90 | -4.2% | 299.5% | SEK 388.2m | SEK 8.10 | PS11.8x | E55.1% | n/a | Capital Goods | ||
CANDLE B | SEK 24.90 | 9.2% | -35.3% | SEK 215.4m | SEK 38.50 | PS1.2x | E98.5% | n/a | Consumer Durables | ||
CINIS | SEK 27.80 | -0.5% | -19.7% | SEK 2.0b | SEK 85.00 | PB5.2x | E53.3% | n/a | Materials | ||
YIELD | SEK 2.37 | -8.5% | -67.3% | SEK 135.8m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
MAGLE | SEK 43.40 | -2.7% | 24.0% | SEK 468.7m | SEK 50.00 | PE60.9x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
EQL | SEK 55.60 | -5.4% | 107.5% | SEK 1.6b | SEK 45.00 | PE71.2x | E58.0% | n/a | Healthcare | ||
CTT | SEK 286.00 | -7.1% | 34.3% | SEK 3.6b | n/a | PE35.2x | E24.8% | 1.9% | Capital Goods | ||
XBRANE | SEK 0.23 | 0.7% | -99.7% | SEK 354.8m | n/a | PS1.9x | E105.2% | n/a | Pharmaceuticals & Biotech | ||
TITA B | SEK 7.58 | 3.6% | 53.1% | SEK 542.0m | SEK 7.00 | PS7.9x | E102.4% | n/a | Real Estate Management and Development | ||
SILEON | SEK 0.48 | -5.9% | -89.3% | SEK 24.3m | n/a | PB1.6x | E109.3% | n/a | Software | ||
SKOLON | SEK 22.80 | -2.6% | -5.8% | SEK 605.2m | SEK 27.50 | PE88.8x | E68.4% | 2.5% | Software | ||
EDYOU | SEK 0.96 | 116.5% | 31.5% | SEK 35.8m | n/a | PS1.1x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.65 | -0.9% | -59.7% | SEK 222.3m | SEK 7.90 | PS30.5x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.30 | -6.9% | -21.8% | SEK 248.8m | SEK 3.65 | PS2.6x | E104.9% | n/a | Tech | ||
PAX | SEK 56.00 | -2.4% | 86.0% | SEK 1.1b | SEK 80.00 | PE44.4x | E57.2% | n/a | Healthcare | ||
WAYS | SEK 22.60 | 3.9% | -24.5% | SEK 182.4m | SEK 38.25 | PS1.6x | E91.9% | 0% | Tech | ||
PCELL | SEK 27.44 | -5.3% | -72.1% | SEK 1.4b | SEK 38.33 | PS4.5x | E80.3% | n/a | Capital Goods | ||
ORGC | SEK 3.55 | -11.0% | -24.3% | SEK 348.3m | SEK 3.00 | PS2.5x | E109.0% | n/a | Materials | ||
CRAD B | SEK 45.20 | -7.5% | 59.2% | SEK 1.5b | SEK 57.00 | PE28.4x | E33.9% | n/a | Healthcare | ||
SYNT | SEK 27.70 | 0% | -13.4% | SEK 1.2b | SEK 30.00 | PE115.3x | E47.4% | 0% | Healthcare | ||
CHECK | SEK 29.70 | 0% | -14.7% | SEK 887.6m | SEK 51.00 | PE293.7x | E82.0% | n/a | Software |